References 2-1995:
Treatment of Hyperthyroidism
L. Chiovato, F. Santini, A. Pinchera


1) Mariotti S., Pinchera A. Role of the immune system in the control of thyroid function.In: Greer M.A. (Ed.), The Thyroid gland. Raven Press, New York, 1990, p.147–177.

2) Cooper D.S. Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD (Eds.),The thyroid. A fundamental and clinical text , 6th ed. JB Lippincot Co., Philadelphia, 1991,p. 887–916.

3) Orgiazzi J., Mornex R. Hyperthyroidism. The thyroid gland. In: M. A. Greer (Ed.), Raven Press, New York, 1990, 405–495.

 4) Franklyn J.A. The management of hyperthyroidism. N. Engl. J. Med. 330: 1731–1738, 1994.

 5) Holm L-H., Hall P., Wilkund K., Lundell G., Berg G., Bjelkengren G., Ceredrquist E.,Ericson U-B., Hallquist A. , Larsson L-G. , Lidberg M., Lindberg S., Tennwall J., Wicklund H., Boice J.D. Jr. Cancer risk after iodine-131 therapy for hyperthyroidism. J. Natl. Cancer Inst. 83: 1072–1077, 1991.

6) Hennemann G., Krenning E.P., Sankaranarayanan K. Place of radioactive iodine in treatment of thyrotoxicosis. Lancet 1:1369–1372, 1986.

7) Reinwein D., Benker G., Lazarus J.H., Alexander W.D., and the European Multicenter Study on Antithyroid Drug. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. J. Clin. Endocrinol. Metab. 76: 1516–1521, 1993.

8) Chiovato L, Lapi P, Fiore E, Tonacchera M, Pinchera A: Thyroid autoimmunity and female gender. J Endocrinol Invest 16: 384, 1993.

9) Chiovato L., Vitti P., Pinchera A. Iodine-induced thyrotoxicosis. In: Monaco F., Satta M.A., Shapiro B., Troncone M. (Eds.), Thyroid diseases; clinical fundamentals and therapy. CRC Press, Boca Raton, 1993, pp. 91–98. 


This paper was supported by grants from the National Research Council (CNR), Rome, Italy; Taget Project: “Biotechnology and Bioinstrumentation”; grant 93.010.70 PF70, Target Project: “Ageing”; grant 93.00437. PF40; Target Profect: “Prevenction and Control of Desease Factors” (FATMA); and by grants from “EEC Stimulation Action-Science Plan Contract N. SC1-CT91-0707” 
Top of this page

Back to Thyroid International 2-1995

Back to ThyroLink Home Page